logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-10. Primary drug and age. EU, Croatia, Norway and Turkey, 2011 or most recent year available

Part (iii) Age distribution, All outpatient clients (%)

Substance<1515–1920–2425–2930–3435–3940–4445+Mean ageAge known (base)Age not known
Opioids0.01.69.918.722.218.914.813.935.2172449231
Cocaine0.13.213.321.123.217.411.610.233.55684775
Stimulants0.714.024.623.716.79.66.04.728.51715132
Hypnotics and sedatives0.34.511.112.614.513.712.131.338.9774718
Hallucinogens0.422.433.019.010.96.43.34.626.39580
Volatile substances21.333.413.210.29.54.93.54.022.97752
Cannabis 3.530.025.617.010.46.04.03.625.398854163
Other substances 1.811.416.917.116.211.29.416.132.7468112
Total1.110.615.618.718.514.410.710.431.9359462533
 

Notes

The number of treatment clients in each country is listed in Table TDI-7.

See also Table TDI-103 on distribution by country and ‘General notes for interpreting data’ on the Explanatory notes and help page.

Source:

Reitox national reports 2012 — Table TDI outpatient and inpatient treatment centres.

Page last updated: Friday, 26 April 2013